Drawing for COVALOGIC

USPTO serial 99732342

COVALOGIC

Reviewed by CopyMark Law Group

Status 688Notice of Allowance
Filing date
Status date
Registration date
—
Examiner
NOVAKOVIC, MIROSLAV
Law office
INTENT TO USE SECTION

What this means

The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.

Status 688: Status 688 means a Notice of Allowance was issued. For intent-to-use applications, you must file a Statement of Use with specimens or request an extension before the deadline — usually six months from the notice date.

Need help with COVALOGIC?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,246*

Plus Government fees of $600

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Lisa C. Pavento

Lisa C. Pavento Meunier Carlin & Curfman LLC999 Peachtree St. NE, Suite 1300Atlanta, GA 30309United States

Goods and services

ClassDescriptionStatusFirst use
001Biological preparations for use in the manufacture of pharmaceuticals; Excipients for use in the manufacture of pharmaceutical preparations; Reagents for scientific or medical research use; Reagents for research purposes; Chemical reagents for non-medical purposes; Chemical reagents, other than for medical or veterinary purposes; Cell culture reagents for scientific and research use; Biochemical reagents used for non-medical purposes; Reagents for scientific purposes; Reagents for medical research; Reagents for scientific use; Cell culture reagents for scientific or research purposesACTIVE—
005Chemical reagents for medical or veterinary purposes; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical preparations for the treatment of infectious diseases; Reagents for medical use; Clinical medical reagents; Reagents for medical purposes; Biological reagents for medical use; Biochemical reagents for medical or veterinary purposes; Therapeutic pharmaceutical for the treatment of neurological diseasesACTIVE—
042Product research and development; Scientific research and development; Research and development of new products; Pharmaceutical research and development; Research and development in the pharmaceutical and biotechnology fields; Consulting services in the field of pharmaceutical research and development; Research and development services in the field of medical preparations; Research and development services in the field of biotechnology; Research and development services in the field of pharmaceutical preparations; Research and development services of new pharmaceutical products; Research and development of medicines; Research and development in the field of pharmaceuticals; Research and development of new products in the field of pharmaceuticals; Research and development in the field of biomedicine; Consulting services for others in the field of design, planning, and implementation project management of scientific research and clinical trials; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing medical and scientific research information in the field of clinical trials; Pharmaceutical drug development servicesACTIVE—
044Medical information services, namely, reporting of consumer authorized clinical testing results directly to the patient; Medical testing for diagnostic or treatment purposes; Medical testing services; Providing medical information, consultancy and advisory servicesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (NOAM): A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.

DateCodeEventWhat it means
Nov 3, 2026NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Sep 8, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Sep 8, 2026PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 2, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Aug 13, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 9, 2026DOCKASSIGNED TO EXAMINER—
Aug 6, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 30, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
Mar 30, 2026NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance